Deficits in sciatic nerve neuropeptide content coincide with a reduction in target tissue nerve growth factor messenger RNA in streptozotocin-diabetic rats: Effects of insulin treatment
- 1 September 1994
- journal article
- Published by Elsevier in Neuroscience
- Vol. 62 (2) , 337-344
- https://doi.org/10.1016/0306-4522(94)90368-9
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain-derived neurotrophic factorMolecular Brain Research, 1994
- Depletion of substance P and calcitonin gene-related peptide in sciatic nerve of rats with experimental diabetes; effects of insulin and aldose reductase inhibitionNeuroscience Letters, 1992
- Monoclonal antibodies distinguishing α and β forms of calcitonin gene-related peptideJournal of Immunological Methods, 1990
- Does capsaicin relieve the pain of diabetic neuropathy?Pain, 1990
- Axonal transport of substance P-like immunoreactivity in ganglioside-treated diabetic ratsJournal of the Neurological Sciences, 1990
- Trophic factors and neuronal survivalNeuron, 1989
- Lack of release of vasoactive intestinal polypeptide and calcitonin gene-related peptide during electrical stimulation of enteric nerves in streptozotocin-diabetic ratsGastroenterology, 1987
- Selective damage of intrinsic calcitonin gene-related peptide-like immunoreactive enteric nerve fibers in streptozotocin-induced diabetic ratsGastroenterology, 1987
- Changes in the somatostatin, substance P and vasoactive intestinal polypeptide content of the gastrointestinal tract following streptozotocin-induced diabetes in the ratDiabetologia, 1985
- Number and evolutionary conservation of α- and β-tubulin and cytoplasmic β- and γ-actin genes using specific cloned cDNA probesCell, 1980